<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TRIFLUOPERAZINE HYDROCHLORIDE</span><br/>(trye-floo-oh-per'a-zeen)<br/><span class="topboxtradename">Novoflurazine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Solazine <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Stelazine, </span><span class="topboxtradename">Terfluzine <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">psychotherapeutic</span>; <span class="classification">antipsychotic phenothiazine</span><br/><b>Prototype: </b>Chlorpromazine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg, 2 mg, 5 mg, 10 mg tablets; 10 mg/mL liquid; 2 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Phenothiazine similar to chlorpromazine. Produces less sedative, cardiovascular, and anticholinergic effects and more prominent
         antiemetic and extrapyramidal effects than other phenothiazines. Antipsychotic effects thought related to blockade of postsynaptic
         dopamine receptors in the brain.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Indicated by increase in mental and physical activity. Strong antipsychotic drug with more prolonged pharmacologic effects
         than that of chlorpromazine.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Management of manifestations of psychotic disorders; "possibly effective" control of excessive anxiety and tension
         associated with neuroses or somatic conditions.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to phenothiazines; comatose states; CNS depression; blood dyscrasias; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Previously detected breast cancer; compromised respiratory function; seizure disorders.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Psychotic Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12 mg b.i.d., may increase up to 20 mg/d in hospitalized patients <span class="rdroute">IM</span> 12 mg q46h (max: 10 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> <i>612 y,</i> 1 mg 12 times/d, may increase up to 15 mg/d in hospitalized patients <span class="rdroute">IM</span> <i>612 y,</i> 1 mg 12 times/d, may increase up to 15 mg/d<br/><br/><span class="indicationtitle">Dementia Behavior</span><br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 0.51 mg 12 times/d, may increase q47d (max: 40 mg in divided doses) <span class="rdroute">IM</span> 1 mg q46h (max: 6 mg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Separate antacid and phenothiazine doses by at least 2 h.</li>
<li>Dilute oral concentrate just before administration with about 60120 mL suitable diluent (e.g., water, fruit juices,
            carbonated beverage, milk, soups, puddings). Avoid coffee or tea near time of taking oral preparation. Explain dosage and
            dilution to patient if drug is to be self-administered.
         </li>
<li>Crush tablet and give with fluid or mix with food if patient will not or cannot swallow pill.</li>
<li>Monitor ingestion of tablet to ensure that patient does not hoard medication.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give IM injection deep into upper outer quadrant of buttock.</li>
<li> 				Note: Slight yellow discoloration of injectable drug reportedly does not alter potency. If color is markedly changed, discard solution. 			</li>
<li>Wash hands if undiluted concentrate is spilled on skin to prevent contact dermatosis.</li>
<li>Store in light-resistant container at 15°30° C (59°86° F) unless otherwise directed.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> insomnia, dizziness, agitation, <span class="speceff-common">extrapyramidal effects,</span> <span class="speceff-life">neuroleptic malignant syndrome</span>. <span class="typehead">Special Senses:</span> Nasal congestion, <span class="speceff-common">dry mouth,</span> blurred vision, pigmentary retinopathy. <span class="typehead">Hematologic:</span> <span class="speceff-life">Agranulocytosis</span>. <span class="typehead">Skin:</span> Photosensitivity, skin rash, sweating. <span class="typehead">GI:</span> Constipation. <span class="typehead">CV:</span> Tachycardia, <span class="speceff-common">hypotension.</span> <span class="typehead">Respiratory:</span> Depressed cough reflex. <span class="typehead">Endocrine:</span> Gynecomastia, galactorrhea. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span> add to CNS depression. <span class="typehead">Herbal:</span> <b>Kava-kava</b> may increase risk and severity of dystonic reactions. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Well absorbed from GI tract. <span class="typehead">Onset:</span> Rapid onset. <span class="typehead">Peak:</span> 23 h. <span class="typehead">Duration:</span> Up to 12 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in bile and feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor HR and BP. Hypotension is a common adverse effect.</li>
<li>Hypotension and extrapyramidal effects (especially akathisia and dystonia) are most likely to occur in patients receiving
            high doses or parenteral administration and in older adults. Withhold drug and notify physician if patient has dysphagia,
            neck muscle spasm, or if tongue protrusion occurs.
         </li>
<li>Monitor I&amp;O ratio and bowel elimination pattern. Check for abdominal distention and pain. Encourage adequate fluid intake
            as prophylaxis for constipation and xerostomia. The depressed patient may not seek help for either symptom or for urinary
            retention.
         </li>
<li>Be aware that since trifluoperazine potentiates analgesics, its use may reduce amount of narcotic required in painful long-term
            illness such as cancer.
         </li>
<li>Agitation, jitteriness, and sometimes insomnia may simulate original neurotic or psychotic symptoms. These adverse effects
            may disappear spontaneously.
         </li>
<li>Expect maximum therapeutic response within 23 wk after initiation of therapy.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take drug as prescribed; do not alter dosing regimen or stop medication without consulting physician.</li>
<li>Consult physician about use of any OTC drugs during therapy.</li>
<li>Do not take alcohol and other depressants during therapy.</li>
<li>Avoid potentially hazardous activities such as driving or operating machinery, until response to drug is known. Drowsiness
            and dizziness may be prominent during this time.
         </li>
<li>Cover as much skin surface as possible with clothing when you must be in direct sunlight. Use a SPF &gt;12 sunscreen on exposed
            skin.
         </li>
<li>Urine may be discolored or reddish brown and this is harmless.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>